Table 1.
Gene | SNP(s) | Tissue | Subtype | OR (95% CI) | P value | H4 (%) | Steiger P value |
---|---|---|---|---|---|---|---|
ABCB6 | rs75450661 | Brain | All glioma | 0.57 (0.44, 0.74) | 2.20 × 10–5 | 97 | 7.41 × 10–6 |
BAIAP2L2 | rs1004764 | Brain | All glioma | 0.65 (0.55, 0.78) | 1.62 × 10–6 | 96 | 2.36 × 10–10 |
GBM | 0.60 (0.49, 0.73) | 2.85 × 10–7 | 81 | 1.25 × 10–9 | |||
EGFR | rs6979446, rs759170 | Brain | GBM | 0.45 (0.38, 0.53) | 9.99 × 10–20 | 81 | 3.53 × 10–6 |
FAM178B | rs13407036 | Brain | All glioma | 1.47 (1.23, 1.77) | 3.59 × 10–5 | 94 | 1.97 × 10–16 |
JAK1 | rs2780902 | Brain | All glioma | 1.21 (1.13, 1.29) | 6.95 × 10–8 | 81 | 6.89 × 10–139 |
GBM | 1.27 (1.17, 1.37) | 1.56 × 10–9 | 95 | 1.84 × 10–134 | |||
MVB12B | rs4837096 | Brain | All glioma | 1.24 (1.12, 1.38) | 5.27 × 10–5 | 97 | 2.53 × 10–23 |
PANK4 | rs2985862 | Blood | All glioma | 0.46 (0.32, 0.67) | 4.30 × 10–5 | 97 | 4.62 × 10–10 |
PICK1 | rs5756894 | Brain | All glioma | 1.72 (1.39, 2.14) | 8.82 × 10–7 | 97 | 4.34 × 10–7 |
GBM | 1.96 (1.54, 2.51) | 6.60 × 10–8 | 92 | 2.13 × 10–6 | |||
PRLR | rs67975005 | Brain | All glioma | 0.66 (0.54, 0.82) | 9.33 × 10–5 | 91 | 1.13 × 10–7 |
RETREG2 | rs1996719 | Brain | All glioma | 0.68 (0.57, 0.80) | 9.54 × 10–6 | 98 | 7.90 × 10–11 |
GBM | 0.67 (0.55, 0.81) | 6.13 × 10–5 | 95 | 9.91 × 10–11 | |||
STMN3 | rs6011016 | Brain | All glioma | 0.36 (0.29, 0.46) | 1.44 × 10–16 | 96 | 1.44 × 10–16 |
GBM | 0.29 (0.22, 0.38) | 4.55 × 10–19 | 97 | 7.88 × 10–3 | |||
TP53 | rs35850753 | Blood | Non-GBM | 0.17 (0.09, 0.32) | 9.61 × 10–8 | 98 | 3.35 × 10–2 |
The colocalisation result for a single, shared causal variant between the gene and all glioma is provided (“H4 (%)”, see “Methods” section). Steiger filtering showed the correct orientation for the direction of effect between gene expression and subtype risk for all results in this table.